Stocks Hitting 52-Week Highs
April 01, 2015 at 10:13 AM EDT
Dyax Corp. (NASDAQ: DYAX) shares touched a new 52-week high of $25.65 after the company said a Phase Ib trial of its DX-2930 drug met ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.